Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer.
about
The NF-κB Pathway and Cancer Stem CellsHallmarks of glycosylation in cancerCytokine-Induced Modulation of Colorectal CancerThe Contrived Mutant p53 Oncogene - Beyond Loss of FunctionsChemoresistance and Cancer-Related Inflammation: Two Hallmarks of Cancer Connected by an Atypical Link, PKCζMultifocal epithelial tumors and field cancerization: stroma as a primary determinantThe therapeutic value of targeting inflammation in gastrointestinal cancersThe role of tumor suppressor p53 in the antioxidant defense and metabolismThe laminin response in inflammatory bowel disease: protection or malignancy?Caught in the cross fire: p53 in inflammation.Drug Discovery via Human-Derived Stem Cell OrganoidsGain of function of mutant p53: R282W on the peak?Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell deathMutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers.ShaoYao decoction ameliorates colitis-associated colorectal cancer by downregulating proinflammatory cytokines and promoting epithelial-mesenchymal transition.NF-κB, an active player in human cancers.Ginsenoside Rg3 Inhibits Constitutive Activation of NF-κB Signaling in Human Breast Cancer (MDA-MB-231) Cells: ERK and Akt as Potential Upstream Targets.Roles of tumor suppressors in regulating tumor-associated inflammation.Methotrexate inhibits NF-κB activity via long intergenic (noncoding) RNA-p21 inductionEpigenetic linkage of aging, cancer and nutrition.Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cellsMechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression.Methotrexate-mediated inhibition of nuclear factor κB activation by distinct pathways in T cells and fibroblast-like synoviocytes.microRNAs: short non-coding bullets of gain of function mutant p53 proteins.The gut microbiota in mouse models of inflammatory bowel disease.NPC1L1 knockout protects against colitis-associated tumorigenesis in mice.Mutant p53 - Heat Shock Response Oncogenic Cooperation: A New Mechanism of Cancer Cell Survival.Mutual reinforcement of inflammation and carcinogenesis by the Helicobacter pylori CagA oncoprotein.Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous nicheSuppression of NF-κB and NF-κB-Regulated Gene Expression by Apigenin through IκBα and IKK Pathway in TRAMP Mice.Doxycycline Promotes Carcinogenesis & Metastasis via Chronic Inflammatory Pathway: An In Vivo ApproachComputational Reconstruction of NFκB Pathway Interaction Mechanisms during Prostate Cancer.BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function.IL-15 suppresses colitis-associated colon carcinogenesis by inducing antitumor immunity.Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal cancer cells.Gene and protein expression of O-GlcNAc-cycling enzymes in human laryngeal cancer.p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathwaysSTK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma.Loss of Stromal IMP1 Promotes a Tumorigenic Microenvironment in the Colon.Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma.
P2860
Q26750605-075C178B-EBDD-4B0F-813D-B00FB4FFAB77Q26752363-F4FBC74E-E9AB-4B40-A568-D6ED9F4C34DDQ26752374-B90711C0-78B9-4CDD-979E-FE51A925B02BQ26772237-53651B29-C807-45C0-B277-47D24C5910C0Q26853683-5CA0DA1D-3E1C-4DEC-8A3B-EFD9FC4F570CQ27005678-80254DC0-4C83-4E6C-9AEE-B4C9DBA3C233Q27024203-5DC1A1FF-ADFF-48D1-9364-E884BF7B2C81Q27027604-31605C1F-0DA3-4666-94ED-8890C91FA287Q27333814-142DC539-13C0-4EE5-80C4-1E72DDC7F508Q27692076-02440E00-43DF-41AC-9609-EA56C04B493CQ28066424-E2FDAC2F-D849-4AA2-A0E4-189F4E98E636Q28068551-240F291F-CB05-4352-99C9-B8D1A4746584Q28080874-71C6041E-0C57-43D9-85EA-A744898711B2Q30354662-EECEC7BA-902D-416C-8CD6-D6DDF6CA5A6FQ33615824-4D20826C-F17A-4EB2-9D2F-FD273FFFF2A5Q34138728-2667A764-04BB-4C46-8B3B-1565EB6E5195Q34305486-41ADD716-0F40-42F6-8AE7-E50ADFCC217BQ34413441-F471D30F-9960-4830-9AF4-DFF4B08DF68BQ34415999-D03FC8BB-FCFE-429C-A0B5-190D36AB0CE0Q34457187-371C8DE3-6C26-4263-BBB4-91FBB5F2F9C4Q34480997-CA36756F-5AAB-43FB-B7B5-E4774188A8C8Q34482050-C9226651-0B17-4515-B557-B4D34979C343Q34727664-943C666B-2EF6-4D4E-89E4-D647D396495BQ34832663-1E566F3F-F0FC-4269-AF4A-9420BC1B493EQ35117031-28A51A3B-C6D5-4DBC-B2A8-6414E842D0DAQ35228987-66EDF79C-5C6E-4AE4-99DF-912994E986FBQ35522196-38D2139E-69F8-423F-905C-886826173FFEQ35574969-6EF23465-8C77-4877-A957-B82D30797D7AQ35717532-2412F097-F61D-44DC-BAB4-A46182C83705Q35778505-0A6E5DE1-6F9E-41D4-BC80-94F826E625B4Q35964572-8F955702-EB20-4C43-AF08-B049EA0E78E8Q35989733-B7B869E0-0B23-4CE5-AE5F-2C0B0F430578Q36032139-1CDCCA40-8CC4-47BF-AF9D-B74EF2170681Q36060253-3276FDC6-C919-4CB8-9D08-E88DD3BFF057Q36214313-CC4690CA-8891-463E-9BCF-1AF77F8273DCQ36214824-4F1B7831-9B59-48FF-80AF-B4F39BEC66FAQ36231932-262470A9-D65F-498A-A44B-376C89863B69Q36266490-CD101889-B70F-48F6-B157-924A07810F7FQ36279559-AF95E549-3882-4184-8122-C750773ABCC5Q36414139-6C2CA93B-22C2-4967-BEBC-B72D7B5FF1EF
P2860
Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Mutant p53 prolongs NF-κB acti ...... -associated colorectal cancer.
@en
type
label
Mutant p53 prolongs NF-κB acti ...... -associated colorectal cancer.
@en
prefLabel
Mutant p53 prolongs NF-κB acti ...... -associated colorectal cancer.
@en
P2093
P2860
P50
P1433
P1476
Mutant p53 prolongs NF-κB acti ...... n-associated colorectal cancer
@en
P2093
Aaron J Schetter
Curtis C Harris
Eli Pikarsky
Guillermina Lozano
Hilla Solomon
Ioannis S Pateras
Nitzan Rosenfeld
Ohad Tarcic
Steven Itzkowitz
Sylvia Wilder
P2860
P304
P356
10.1016/J.CCR.2013.03.022
P577
2013-05-01T00:00:00Z